News

Stocktwits on MSN1h
Retail Bulls Stick With Sarepta After 8-Year-Old Patient’s Death Deemed Unrelated To DMD Gene Therapy
Retail sentiment around Sarepta Therapeutics remained upbeat on Monday after the company said Friday that the death of an ...
TipRanks on MSN13h
Sarepta says eight-year-old death deemed unrelated to Elevidys
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> ...
Wall Street Brunch: Four Mag 7 Earnings And Fed On Tap
The Fed is expected to keep rates steady, but Powell will get questions on Fed independence. Apple, Microsoft, Meta and ...
GEN - Genetic Engineering and Biotechnology News17h
FDA Probes Death of Brazilian Boy Linked to Sarepta’s Elevidys
The FDA is investigating the death last month of an eight-year-old boy in Brazil who had received Sarepta Therapeutics’ Elevidys® (delandistrogene moxeparvovec-rokl)—though the company and its ...
GEN - Genetic Engineering and Biotechnology News13h
StockWatch: Abivax Shares Leap on Phase III Ulcerative Colitis Data, $747.5M Offering
Abivax dazzled investors and analysts with positive data from a pair of Phase III induction trials assessing obefazimod in adults with moderately to severely active ulcerative colitis. The results ...